From: Walsh, Maria R
Sent: Tuesday, November 02, 2004 2:33 PM
To: Butler, Jennie C
Subject: FW: RDRC Public Meeting

Jennie,

Final presentation attached for Docket No. 2004N-0432

Maria

-----Original Message-----
From: Smith, Gary T. MD [mailto:GSmith@mc.utmck.edu] 
Sent: Tuesday, November 02, 2004 2:26 PM
To: 'Walsh, Maria R'
Subject: RE: RDRC Public Meeting


Thank you for your email confirming my opportunity to present at the upcoming RDRC public meeting.  I have attached a copy of my PowerPoint presentation for your review.  -Gary Smith


 <<RDRC Public Meeting 11/16/04>> 

> ----------
> From: 	Walsh, Maria R
> Sent: 	Tuesday, October 26, 2004 12:45 PM
> To: 	'Smith, Gary T. MD'
> Subject: 	RE: RDRC Public Meeting
> 
> Dr. Smith,
> 
> You are scheduled to present at the November 16th RDRC public meeting 
> during the 2:45 - 4:00 pm public presentation period. Your name will 
> appear on the
> agenda as follows:
> 
> 	Gary T. Smith, MD, RDRC Chair, University of Tennessee Medical Center
> 
> Please let me know if you have any edits by close of business November 
> 1, 2004.
> 
> Thank you.
> 
> Maria
> 
> Maria R. Walsh, RN, MS
> Project Management Officer
> 
> FDA/CDER/OND
> Office of Drug Evaluation III Immediate Office (HFD-103)
> 5600 Fishers Lane
> Rockville, Maryland 20857
> Phone: (301) 827-3139
> Fax: (301) 480-3761
> e-mail: walsh@cder.fda.gov
> -----Original Message-----
> From: Smith, Gary T. MD [mailto:GSmith@mc.utmck.edu]
> Sent: Tuesday, October 19, 2004 12:11 PM
> To: 'walsh@cder.fda.gov'
> Subject: RDRC Public Meeting
> 
> 
> The attached abstract is to be considered for presentation at the 
> upcoming RDRC public meeting, focused on question 1a. The presentation 
> should take no longer than 5 minutes.  Thanks for considering this 
> request.
> 
> Gary T. Smith, MD
> University of Tennessee Medical Center
> 1924 Alcoa Highway
> Knoxville, TN  37919
> 865-544-9818
> gsmith@mc.utmck.edu
> 
> 
>  <<RDRC Meeting 11/04.doc>>
> 
>